GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

A manufacturing issue with Abbott FreeStyle Libre 3 sensors led to inaccurate readings, affecting about 3 million sensors worldwide.

Smoking, perianal disease, and microscopic margin inflammation significantly increases postoperative recurrence risk after ileocolic resection for CD.

Over one-third of individuals with Crohn disease experience post-traumatic stress disorder symptoms following an operation.

Obesity was associated with faster amyloid accumulation and blood biomarker increases in a longitudinal Alzheimer disease study.

A significant association was observed between HCV coinfection and increased risk for DILI in patients undergoing TB therapy.

Orforglipron as an adjunct to lifestyle modification was better than placebo for weight and cardiometabolic measures of health.

G-POEM provides durable symptom relief and improved gastric emptying for refractory gastroparesis, with clinical benefits sustained up to 5 years.

Dr Richard Pazdur retired from leading the FDA’s Center for Drug Evaluation and Research amid internal disagreements over approval processes.

Ablation therapy demonstrated comparable effectiveness for HCC in patients with hepatitis B-related recompensated vs compensated cirrhosis.

Mucosal integrity testing during endoscopy accurately predicts long-term GERD symptom resolution and PPI discontinuation.

Global GERD burden has increased from 1990 to 2021, with the highest rates concentrated in low- and low-middle-socioeconomic regions.